Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

INTRODUCTION: Demographic and disease characteristics may impact response to psoriasis therapies. The objective of this study is to explore the safety and efficacy profile of secukinumab in North American (NA) versus non-NA patients with moderate to severe psoriasis. METHODS: Data were pooled from f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dermatol Ther (Heidelb)
Main Authors: Pariser, David, Frankel, Ellen, Schlessinger, Joel, Poulin, Yves, Vender, Ronald, Langley, Richard G., Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5825316/
https://ncbi.nlm.nih.gov/pubmed/29218492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-017-0211-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados